Detalhe da pesquisa
1.
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Cancer
; 125(22): 3974-3984, 2019 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31318460
2.
Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
BMC Cancer
; 19(1): 620, 2019 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234810
3.
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
BMC Cancer
; 19(1): 517, 2019 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31146717
4.
Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians.
Curr Oncol Rep
; 20(Suppl 1): 15, 2018 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508148
5.
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.
Oncologist
; 20(8): 873-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26112003
6.
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.
Breast Cancer Res Treat
; 122(2): 409-18, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20454927
7.
Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey.
Prev Med Rep
; 10: 332-336, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29868388
8.
Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer.
Eur J Cancer
; 45(17): 2940-6, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19683429
9.
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
J Clin Oncol
; 25(33): 5210-7, 2007 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17968020